These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8074454)

  • 1. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G; Gittel H; Ben-Efraim S
    Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation in vitro of peritoneal macrophages by a nocardia fraction.
    Ben-Efraim S; Rashid G; Gittel H; Tax C; Ciorbaru RB
    Anticancer Res; 1994; 14(2A):449-52. PubMed ID: 8017846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asialo-positive cells are overexpressed whereas IL-2 induced LAK activity is impaired in mice hyperimmunized with an immunomodulating mycobacterial fraction.
    Rashid G; Gittel H; Ben-Efraim S
    In Vivo; 1993; 7(5):463-6. PubMed ID: 8110993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions.
    Petricevich VL; Alves RC
    Mediators Inflamm; 2000; 9(6):261-9. PubMed ID: 11213909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
    Sato K; Tomioka H; Saito H
    Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
    Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
    Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
    Chen BC; Hsieh SL; Lin WW
    J Leukoc Biol; 2001 Feb; 69(2):280-8. PubMed ID: 11272279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution.
    Chokri M; Freudenberg M; Galanos C; Poindron P; Bartholeyns J
    Anticancer Res; 1989; 9(4):1185-90. PubMed ID: 2817800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism.
    Murphy C; Newsholme P
    Clin Sci (Lond); 1999 Jan; 96(1):89-97. PubMed ID: 9857111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I; Niitsu Y; Watanabe N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate inhibits LPS-induced tumor necrosis factor production in vivo.
    Durez P; Appelboom T; Vray B; Pira C; Goldman M
    Eur Cytokine Netw; 1998 Dec; 9(4):669-72. PubMed ID: 9889412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and regulation of IL-15 expression in murine macrophages.
    Doherty TM; Seder RA; Sher A
    J Immunol; 1996 Jan; 156(2):735-41. PubMed ID: 8543827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF revisited: TNF-independent antitumor activity in sera of mice sensitized with Propionibacterium acnes and challenged with lipopolysaccharide.
    Schwamberger G; Hammerl P; Ferber E; Freudenberg M; Galanos C
    J Leukoc Biol; 2003 Dec; 74(6):1056-63. PubMed ID: 12960265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Poindron P
    Anticancer Res; 1988; 8(1):145-51. PubMed ID: 3358630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.